Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
1.420
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cns Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Pricing of Registered Direct, Concurrent Private Placement
June 26, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
June 26, 2024
Via
ACCESSWIRE
Brain Cancer in Kids Could Soon Be Detected by 10-Minute Scan
June 21, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc.(NASDAQ: CNSP) Enters in Purchase Agreements, Announces Pricing
June 17, 2024
Via
Investor Brand Network
CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase
May 20, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Present at the LSX World Congress 2024
April 23, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
April 21, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
June 14, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Reverse Stock Split
June 03, 2024
Via
Investor Brand Network
Virginia Tech Clinical Trial Seeks End to Brain Cancer Surgery
June 03, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Reverse Stock Split
June 03, 2024
Via
ACCESSWIRE
New Research Sheds Light on the Initial Stages of Brain Cancer Development
March 18, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at 2024 Healthcare Company Showcase
May 20, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Q1 2024 Financial, Business Report
May 16, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Reports First Quarter 2024 Financial Results
May 16, 2024
Via
ACCESSWIRE
New mRNA Vaccine Offers Hope Against Glioblastoma
May 15, 2024
Via
Investor Brand Network
Researchers Seek to Develop Genetically Engineered Brain Cancer Treatment
April 26, 2024
Via
Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024
April 23, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted in Upcoming Virtual Investor Lunch Break Event
April 22, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients
April 15, 2024
Via
Investor Brand Network
Researchers Link Hormone Treatments to Heightened Risk of Brain Tumors
April 08, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases FY 2023 Financial Report, Corporate Update
April 02, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
April 01, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Present at Two Investor Conferences in April
April 01, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors
March 18, 2024
Via
Investor Brand Network
Study Shows Troops That Sustain Serious Brain Injuries Have Higher Risk of Brain Cancer
February 26, 2024
Via
Investor Brand Network
Scientists Start Trialing First Blood Test Against Brain Cancer
February 05, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Information on $4M Public Offering Pricing
January 30, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
January 29, 2024
Via
ACCESSWIRE
Novel Brain Scan Technique Exposes Vulnerability of Gliomas
January 23, 2024
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.